Enterprise Pharmacy Forward

Sign in Subscribe

Latest

Redefining retail: Geisinger Pharmacy’s transformation toward patient-centered, tech-enabled care

Jenny Plummer The overall Geisinger Retail Pharmacy landscape has undergone a remarkable transformation since 2020, driven largely by the pandemic and subsequent shifts in medication distribution, consumer expectations and the growing influence of technology on the patient experience. Like many others in the industry, Geisinger Pharmacy has shifted focus from

One year of CAR-T therapy: Advancing personalized cancer treatment at Geisinger

Lori Stopper, Kayla Aufiero Geisinger Medical Center in Danville and the Geisinger Cancer Institute have successfully completed the first year of chimeric antigen receptor T-cell (CAR-T) therapy infusions, treating 12 patients with the goal of achieving long-term remission — or even a potential cure — for cancers that are

Pharmacy technician certification pathway established through Stepful partnership

Pharmacy technician certification pathway established through Stepful partnership

Daniel Longyhore In July 2024, Enterprise Pharmacy initiated a strategic partnership with Stepful Inc. to support pharmacy technicians employed at Geisinger in meeting certification requirements through structured training and examination preparation. This collaboration provides a formal pathway for technicians to pursue certification through either the Pharmacy Technician Certification Board or

Navigating pharmaceutical tariffs: Preparing for price pressures and supply chain disruptions

Navigating pharmaceutical tariffs: Preparing for price pressures and supply chain disruptions

Jamie Miller Tariffs on imported pharmaceuticals are likely to lead to increased drug prices and potential shortages, impacting patients, providers and healthcare systems. While tariffs aim to protect domestic industries, public health experts anticipate that the costs of tariffs on imported drugs will likely be passed on to consumers, potentially

Expanding clinical impact: Specialty MTDM’s role in collaborative, patient-centered care

Susanne Burns, Amanda Popko, Allyson Hess and Allison Cebulko Specialty MTDM continues to expand its clinical footprint through innovative partnerships and interdisciplinary care models that enhance patient access, optimize therapy and improve outcomes across a growing number of specialties. These initiatives demonstrate the critical role of pharmacists in advancing systemwide

Unlocking the power of pharmacogenomics: MyCode’s role in safer, smarter prescribing

Unlocking the power of pharmacogenomics: MyCode’s role in safer, smarter prescribing

Ryley Uber The Geisinger MyCode® Community Health Initiative has been underway for nearly 2 decades, positively influencing our understanding of how genomics affect health while enabling pathways for clinical confirmation of genomic results. Yet a key question remains: How can MyCode pharmacogenomic (PGx) data be used to improve medication outcomes

Balancing demand and evidence: MTDM’s oversight of GLP-1 prescribing

Susanne Burns, Amanda Popko and Allison Cebulko In response to the rising cost and growing demand for GLP-1 receptor agonists, Specialty MTDM, in collaboration with the Value & Strategy team, implemented a systemwide initiative designed to make sure prescribing practices remain clinically appropriate and financially sustainable. GLP-1 therapies,